(Retracted) Therapeutic effect of immune trioxy autologous blood transfusion combined with ultrasound-guided paravertebral injection in postherpetic neuralgia treatment

Abstract

We analyze the clinical efficacy of immune trioxy autotransfusion combined with ultrasound-guided paravertebral injection of trioxy in the treatment of postherpetic neuralgia (PHN). A total of 92 patients with thoracolumbar PHN treated in the pain department of our hospital from January 2020 to January 2022 were selected as the subjects of our study, and the patients who received conventional treatment were included in the conventional treatment group (n = 46). Patients who received visual communicator-based immunotrioxic autologous blood transfusion combined with ultrasound-guided paravertebral trioxic injection were included in the combined treatment group (n = 46). We observed the clinical efficacy, changes in pain degree, and quality of life of patients after treatment and obtained the following research results. The total effective rate of combined treatment group increased significantly compared to that of conventional treatment group (P < 0.05). The visual analog scale scores were significantly decreased after treatment, and the scores of the combined treatment group decreased significantly than those of the conventional treatment group (all P < 0.05). The brief pain inventory scores were significantly decreased after treatment, and the scores of the combined treatment group decreased significantly compared to the conventional treatment group (all P < 0.05). There is a significant correlation between the degree of pain and the quality of life. The above research results can prove that the combination of immune trioxy autologous blood transfusion based on visual communication device and ultrasound guided paravertebral injection of trioxy in the treatment of patients with thoracolumbal PHN has good clinical efficacy, which can help patients reduce pain and improve quality of life. Immune trioxy autologous blood transfusion combined with ultrasound-guided trioxy paravertebral injection based on visual communicator is worthy of clinical application.